Stock Price Quote

ARVEE LABORATORIES (INDIA) LTD.

NSE : ARVEEBSE : ISIN CODE : INE006Z01016Industry : ChemicalsHouse : Private
BSE0.000 (0 %)
PREV CLOSE ( ) NA
OPEN PRICE ( ) 0.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH ( )0.00 0.00
52 WK LOW / HIGH ( )0 0
NSE167.424.31 (+2.64 %)
PREV CLOSE( ) 163.11
OPEN PRICE ( ) 168.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 167.42 (42)
VOLUME 923
TODAY'S LOW / HIGH( ) 164.10 168.50
52 WK LOW / HIGH ( )129.11 290.78
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 27-01 2012
Management Info
Shalin Sudhakarbhai Patel - Chairman Shalin Sudhakarbhai Patel - Managing Director
Registered Office

Address 403, Entice, Nr. Jayantilal Park Brts,Iscon Bopal Road,Ambii,
Ahmedabad,
Gujarat-380058

Phone 02717-430479

Email compliance@arveelabs.com

Website www.arveelabs.com

Registrars Details
Bigshare Services Pvt Ltd
Office No S6-2, 6th Floor, Pinnacle Business Park,Next to Ahura Centre, Mahakali Caves Road,Andheri (E),Mumbai
Listing : NSE

NEWS

13Apr General Announcement
Significant movement in price has been observed in Arvee Laboratories (I..
27Mar Closure of Trading Window
Arvee Laboratories (India) Limited has informed the Exchange regarding t..
06Mar General Announcement
Significant movement in price has been observed in Arvee Laboratories (I..
13Feb Outcome of Board Meeting
Arvee Laboratories (India) Limited has submitted to the Exchange, the fi..
09Feb Clarification
Arvee Laboratories (India) Limited has informed the Exchange regarding C..

Financials

in Millions
QTR Dec 25 ANNUAL 25
Net Profit18.2621.46
Gross Profit 13.91 28.7
Operating Profit 17.642.68
Net Sales 97.8384.87

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Privi Speciality Che (BSE)
peergroup  3126.55 (6.28%)
M.Cap ( in Cr)12213.15
Keltech Energies (BSE)
peergroup  4412.25 (3.33%)
M.Cap ( in Cr)441.23
Solar Industries (BSE)
peergroup  15086.85 (0.67%)
M.Cap ( in Cr)136520.99
Pidilite Inds. (BSE)
peergroup  1393.25 (4.70%)
M.Cap ( in Cr)141801.55
Transpek Industry (BSE)
peergroup  1135.70 (5.73%)
M.Cap ( in Cr)634.35

Shareholding Pattern

PROMOTERS 73.5%
NON-INSTITUTION 26.5%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Arvee Laboratories (India) Ltd.

Arvee Laboratories (India) Ltd. was incorporated in the year 2012. Its today's share price is 0. Its current market capitalisation stands at Rs 184.5 Cr. In the latest quarter, company has reported Gross Sales of Rs. 384.87 Cr and Total Income of Rs.391.46 Cr. The company's management includes Saurin Ajitbhai Gandhi, Raina Singh, Sachin Kanwarlal Kansal, Praveen Kumar Mishra, Neetu Rishi Jalan, Shalini Hitesh Jalan, Shalin Sudhakarbhai Patel, Shalin Sudhakarbhai Patel.

It is listed on the BSE with a BSE Code of  , NSE with an NSE Symbol of ARVEE and ISIN of INE006Z01016. It's Registered office is at 403, Entice, Nr. Jayantilal Park Brts,Iscon Bopal Road,AmbiiAhmedabad-380058, Gujarat. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Bharatiya & Malkani, Jaimin Deliwala & Co, KCJM & Associates, Nirav Patel & Associates

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.